[1] Ghaffarpour N, Baselga E, Boon LM, et al.The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations[J]. Eur J Med Genet, 2022, 65(12): 104637. [2] Johnson AB, Richter GT.Surgical considerations in vascular malformations[J]. Tech Vasc Interv Radiol, 2019, 22(4): 100635. [3] Acevedo JL, Shah RK, Brietzke SE.Nonsurgical therapies for lymphangiomas: a systematic review[J]. Otolaryngol Head Neck Surg, 2008, 138(4): 418-424. [4] Manning SC, Perkins J.Lymphatic malformations[J]. Curr Opin Otolaryngol Head Neck Surg, 2013, 21(6): 571-575. [5] Pessanha I, Bravo M, Piedade C, et al.Complex lymphatic malformations in pediatrics: a review of treatment options[J]. Minerva Pediatr (Torino), 2022, 74(1): 70-80. [6] Elluru RG, Balakrishnan K, Padua HM.Lymphatic malformations: diagnosis and management[J]. Semin Pediatr Surg, 2014, 23(4): 178-185. [7] Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA[J]. J Pediatr, 2015, 166(4): 1048-1054.e1-e5. [8] Zenner K, Cheng CV, Jensen DM, et al.Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations[J]. JCI Insight, 2019, 4(21): e129884. [9] Ricci KW, Hammill AM, Mobberley‐Schuman P, et al. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease[J]. Pediatr Blood Cancer, 2019, 66(5): e27614. [10] Maruani A, Tavernier E, Boccara O, et al.Sirolimus (rapamycin) for slowflow malformations in children: the observational-phase randomized clinical PERFORMUS Trial[J]. JAMA Dermatol, 2021, 157(11): 1289-1298. [11] Harbers VEM, Bouwman FCM, van Rijnsoever IMP, et al. Magnitude and relevance of change in health-related quality of life in patients with vascular malformations treated with sirolimus[J]. Front Med (Lausanne), 2023, 10: 1155476. [12] Delestre F, Venot Q, Bayard C, et al. Alpelisib administration reduced lymphatic malformations in a mouse model and in patients[J]. Sci Transl Med, 2021, 13(614): eabg0809. [13] Sheppard SE, March ME, Seiler C, et al.Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition[J]. JCI Insight, 2023, 8(9): e155888. [14] Li D, March ME, Gutierrez-Uzquiza A, et al.ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor[J]. Nat Med, 2019, 25(7): 1116-1122. [15] Kato M, Watanabe S, Watanabe A, et al.Flow-oriented venous anastomosis to control lymph flow of lymphatic malformation[J]. Plast Reconstr Surg Glob Open, 2019, 7(7): e2199. [16] Yoshida S, Imai H, Roh S, et al.Cystic lymphatic malformation with lymphedema treated by lymphaticovenular anastomosis combined with ethanol sclerotherapy[J]. Plast Reconstr Surg Glob Open, 2023, 11(3): e4871. [17] Yoshida S, Imai H, Roh S, et al.Combined treatment with lymphaticovenular anastomosis and ethanol sclerotherapy for cystic lymphangioma in a limb[J]. Plast Reconstr Surg Glob Open, 2022, 10(5): e4348. [18] Ishiura R, Mitsui K, Danno K, et al.Successful treatment of large abdominal lymphatic malformations and chylous ascites with intra-abdominal lymphovenous anastomosis[J]. J Vasc Surg Venous Lymphat Disord, 2021, 9(2): 499-503. [19] Furuse K, Kato M, Morishita Y, et al.Lymphatic malformation treated with lymphatic malformation-venous anastomosis under local anesthesia[J]. Plast Reconstr Surg Glob Open, 2020, 8(7): e2974. [20] Onoda S, Komagoe S.Lymphaticovenular anastomosis for Klippel-Trenaunay-Weber syndrome[J]. Int J Surg Case Rep, 2019, 58: 67-69. [21] Giacalone G, Yamamoto T, Belva F, et al.The application of virtual reality for preoperative planning of lymphovenous anastomosis in a patient with a complex lymphatic malformation[J]. J Clin Med, 2019, 8(3): 371-378. [22] Kato M, Watanabe S, Iida T, et al.Venous anastomosis procedure for treatment of lymphatic malformation in Klippel-Trenaunay syndrome[J]. J Pediatr Surg Case Rep, 2017, 20: 1-3. [23] Kato M, Watanabe S, Iida T, et al.Peri-orbital lymphangioma treated by lymphatic-venous anastomosis with indocyanine green lymphography analysis[J]. J Pediatr Surg Case Rep, 2017, 23: 9-14. [24] Yamamoto T, Yamamoto N, Yoshimatsu H, et al.Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels[J]. Plast Reconstr Surg, 2017, 140(4): 734-741. [25] Nagy BI, Mohos B, Tzou CJ.Imaging modalities for evaluating lymphedema[J]. Medicina (Kaunas), 2023, 59(11): 2016. [26] Chang DW, Suami H, Skoracki R.A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema[J]. Plast Reconstr Surg, 2013, 132(5): 1305-1314. [27] Ogata F, Narushima M, Mihara M, et al.Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema[J]. Ann Plast Surg, 2007, 59(2): 180-184. [28] Szuba A, Shin WS, Strauss HW, et al.The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema[J]. J Nucl Med, 2003, 44(1): 43-57. [29] Tiwari P, Coriddi M, Salani R, et al.Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options[J]. World J Surg Oncol, 2013, 11: 237. [30] Lohrmann C, Foeldi E, Bartholomae JP, et al.Gadoteridol for MR imaging of lymphatic vessels in lymphoedematous patients: initial experience after intracutaneous injection[J]. Br J Radiol, 2007, 80(955): 569-573. [31] Lee E, Biko DM, Sherk W, et al.Understanding lymphatic anatomy and abnormalities at imaging[J]. RadioGraphics, 2022, 42(2): 487-505. [32] Lu Q, Xu J, Liu N.Chronic lower extremity lymphedema: a comparative study of high-resolution interstitial MR lymphangiography and heavily T2-weighted MRI[J]. Eur J Radiol, 2010, 73(2): 365-373. [33] Mitsumori LM, McDonald ES, Wilson GJ, et al. MR lymphangiography: how I do it[J]. J Magn Reson Imaging, 2015, 42(6): 1465-1477. [34] Pappalardo M, Cheng MH.Lymphoscintigraphy for the diagnosis of extremity lymphedema: current controversies regarding protocol, interpretation, and clinical application[J]. J Surg Oncol, 2020, 121(1): 37-47. [35] Laine JB, Howard JM.Experimental lymphatico-venous anastomosis[J]. Surg Forum, 1963, 14: 111-112. [36] O’Brien BM, Sykes P, Threlfall GN, et al. Microlymphaticovenous anastomoses for obstructive lymphedema[J]. Plast Reconstr Surg, 1977, 60(2): 197-211. [37] Kojimahara T, Kageyama T.Octopus anastomosis: selection of anastomotic configuration in lymphaticovenular anastomosis according to vessels' conditions[J]. Breast Cancer Res Treat, 2021, 186(3): 887-888. [38] Onoda S, Satake T, Kinoshita M.Relationship between lymphaticovenular anastomosis outcomes and the number and types of anastomoses[J]. J Surg Res, 2022, 269: 103-109. [39] Masia J, Olivares L, Koshima I, et al.Barcelona consensus on supermicrosurgery[J]. J Reconstr Microsurg, 2014, 30(1): 53-58. [40] Nuri T, Asaka A, Otsuki Y, et al.Modified preparatory intravascular stenting technique in super-microsurgical lymphaticovenular anastomosis for the treatment of lymphedema[J]. Plast Reconstr Surg Glob Open, 2023, 11(10): e5308. [41] Miyamoto S, Sakuraba M, Asano T, et al.Optimal technique for microvascular anastomosis of very small vessels: comparative study of three techniques in a rat superficial inferior epigastric arterial flap model[J]. J Plast Reconstr Aesth Surg, 2010, 63(7): 1196-1201. [42] Narushima M, Koshima I, Mihara M, et al.Intravascular stenting (IVaS) for safe and precise supermicrosurgery[J]. Ann Plast Surg, 2008, 60(1): 41-44. [43] Karakawa R, Yoshimatsu H, Kamiya K, et al.Supermicrosurgical suture-stent technique for a lymphaticovenular bypass[J]. J Clin Med, 2021, 10(12): 2595. [44] Akita S, Mitsukawa N, Kuriyama M, et al.External valvuloplasty for subcutaneous small veins to prevent venous reflux in lymphaticovenular anastomosis for lower extremity lymphedema[J]. Plast Reconstr Surg, 2013, 132(4): 1008-1014. [45] Akita S, Yamaji Y, Tokumoto H, et al.Prevention of venous reflux with full utilization of venoplasty in lymphaticovenular anastomosis[J]. J Plast Reconstr Aesthet Surg, 2020, 73(3): 537-543. [46] Yamamoto T, Giacalone G.Lymphatic vessel grafting for prevention of venous reflux into a sclerotic lymphatic vessel in supermicrosurgical lymphaticovenular anastomosis[J]. J Plast Reconstr Aesthet Surg, 2016, 69(3): e67-e68. [47] Chan VSH, Narushima M, Hara H, et al.Local anesthesia for lymphaticovenular anastomosis[J]. Ann Plast Surg, 2014, 72(2): 180-183. [48] Yoshida S, Koshima I, Imai H, et al.Microscope-induced thermal burns during lymphaticovenular anastomosis[J]. Ann Plast Surg, 2020, 84(5): e24-e26. [49] Winters H, Tielemans HJP, Sprangers PN, et al.Peri-operative care for patients undergoing lymphaticovenular anastomosis: a systematic review[J]. J Plast Reconstr Aesthet Surg, 2017, 70(2): 178-188. [50] Masia J, Pons G, Nardulli ML.Combined surgical treatment in breast cancer-related lymphedema[J]. J Reconstr Microsurg, 2016, 32(1): 16-27. |